Nifty

:

22402.05

Sensex

:

73882.01

65.65 (0.29%)
793.68 (1.09%)

Login

Nifty
Sensex

:
:

22402.05
73882.01

65.65 (0.29%)
793.68 (1.09%)

Godavari Drugs Ltd.

Pharmaceuticals & Drugs

Rating :

52/99

BSE: 530317 | NSE: Not Listed

Watchlist

NSE BSE

98.97

22-Apr-2024

Open
High
Low
Previous Close

97.00
100.45
97.00
99.01

Volume
Traded Value (lacs)
52 Week High
52 Week Low

56
6.36
114.00
76.21

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

74.53
17.67
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

105.74
N/A
2.05

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

32.70
13.83
9.17

EBITDA CAGR (%)

10 Years
5 Years
3 Years

18.35
12.60
0.16

PAT CAGR (%)

10 Years
5 Years
3 Years

9.35
25.65
-2.82

P:E (Median)

8 Years
5 Years
3 Years

15.31
11.12
12.77

P:BV (Average)

8 Years
5 Years
3 Years

1.70
1.70
1.92

EV:EBITDA (Average)

8 Years
5 Years
3 Years

7.46
7.10
7.71

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 43.11 39.16 10.09% 39.54 40.55 -2.49% 35.42 42.55 -16.76% 37.37 44.28 -15.61%
Expenses 39.59 36.89 7.32% 36.48 37.98 -3.95% 33.17 40.15 -17.38% 34.69 41.58 -16.57%
EBITDA 3.52 2.27 55.07% 3.06 2.57 19.07% 2.25 2.40 -6.25% 2.68 2.70 -0.74%
EBIDTM 8.17% 5.79% 7.75% 6.33% 6.35% 5.64% 7.18% 6.11%
Other Income 0.05 0.30 -83.33% 0.00 0.13 -100.00% 0.45 0.07 542.86% 0.16 0.12 33.33%
Interest 1.27 1.10 15.45% 1.30 1.06 22.64% 1.11 0.74 50.00% 1.03 0.62 66.13%
Depreciation 0.50 0.51 -1.96% 0.49 0.47 4.26% 0.47 0.46 2.17% 0.50 0.42 19.05%
PBT 1.74 0.96 81.25% 1.27 1.17 8.55% 1.12 1.27 -11.81% 1.54 1.78 -13.48%
Tax 0.52 0.29 79.31% 0.42 0.31 35.48% 0.31 0.34 -8.82% 0.21 0.52 -59.62%
PAT 1.22 0.67 82.09% 0.86 0.86 0.00% 0.81 0.92 -11.96% 1.33 1.27 4.72%
PATM 2.83% 1.71% 2.16% 2.13% 2.29% 2.16% 3.56% 2.86%
EPS 1.63 0.89 83.15% 1.14 1.15 -0.87% 1.08 1.23 -12.20% 1.78 1.69 5.33%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 155.44 159.62 161.11 122.67 95.70 83.54 64.45 75.60 71.12 54.85 9.43 Net Sales Growth -6.67% -0.92% 31.34% 28.18% 14.56% 29.62% -14.75% 6.30% 29.66% 481.65% Cost Of Goods Sold 121.97 128.06 130.45 96.59 76.67 64.91 49.27 58.94 58.68 40.41 1.14 Gross Profit 33.47 31.57 30.65 26.08 19.03 18.63 15.18 16.66 12.44 14.44 8.29 GP Margin 21.53% 19.78% 19.02% 21.26% 19.89% 22.30% 23.55% 22.04% 17.49% 26.33% 87.91% Total Expenditure 143.93 149.70 149.82 112.83 89.66 78.06 60.39 70.37 66.63 49.06 7.59 Power & Fuel Cost - 6.66 5.46 4.76 4.84 4.20 3.98 4.57 2.71 2.97 2.36 % Of Sales - 4.17% 3.39% 3.88% 5.06% 5.03% 6.18% 6.04% 3.81% 5.41% 25.03% Employee Cost - 4.84 4.96 3.94 3.45 3.45 2.67 2.38 2.17 2.01 1.46 % Of Sales - 3.03% 3.08% 3.21% 3.61% 4.13% 4.14% 3.15% 3.05% 3.66% 15.48% Manufacturing Exp. - 3.55 4.43 3.41 1.26 1.81 1.40 2.11 1.23 2.09 0.98 % Of Sales - 2.22% 2.75% 2.78% 1.32% 2.17% 2.17% 2.79% 1.73% 3.81% 10.39% General & Admin Exp. - 0.83 0.71 0.67 0.76 0.41 0.52 0.51 0.52 0.37 0.21 % Of Sales - 0.52% 0.44% 0.55% 0.79% 0.49% 0.81% 0.67% 0.73% 0.67% 2.23% Selling & Distn. Exp. - 0.17 0.38 0.30 0.28 0.18 0.15 0.20 0.19 0.09 0.01 % Of Sales - 0.11% 0.24% 0.24% 0.29% 0.22% 0.23% 0.26% 0.27% 0.16% 0.11% Miscellaneous Exp. - 5.60 3.42 3.16 2.40 3.09 2.39 1.67 1.14 1.12 0.01 % Of Sales - 3.51% 2.12% 2.58% 2.51% 3.70% 3.71% 2.21% 1.60% 2.04% 15.06% EBITDA 11.51 9.92 11.29 9.84 6.04 5.48 4.06 5.23 4.49 5.79 1.84 EBITDA Margin 7.40% 6.21% 7.01% 8.02% 6.31% 6.56% 6.30% 6.92% 6.31% 10.56% 19.51% Other Income 0.66 0.66 0.28 0.41 0.33 0.24 0.68 0.80 0.19 0.30 0.12 Interest 4.71 3.93 2.85 3.32 2.91 2.90 2.44 2.52 1.88 0.67 0.21 Depreciation 1.96 1.94 1.70 1.22 1.16 1.09 0.99 0.81 0.63 0.68 1.05 PBT 5.67 4.71 7.02 5.71 2.29 1.75 1.31 2.71 2.18 4.73 0.70 Tax 1.46 1.15 1.78 1.58 0.29 0.54 0.48 0.90 0.83 1.09 -0.85 Tax Rate 25.75% 23.28% 25.36% 27.67% 12.66% 30.86% 36.64% 33.21% 38.07% 23.04% -121.43% PAT 4.22 3.79 5.25 4.13 2.00 1.21 0.83 1.81 1.35 3.65 1.55 PAT before Minority Interest 4.22 3.79 5.25 4.13 2.00 1.21 0.83 1.81 1.35 3.65 1.55 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 2.71% 2.37% 3.26% 3.37% 2.09% 1.45% 1.29% 2.39% 1.90% 6.65% 16.44% PAT Growth 13.44% -27.81% 27.12% 106.50% 65.29% 45.78% -54.14% 34.07% -63.01% 135.48% EPS 5.63 5.05 7.00 5.51 2.67 1.61 1.11 2.41 1.80 4.87 2.07

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 33.42 29.63 24.39 20.26 18.26 17.05 16.22 14.41 13.06 9.51 Share Capital 7.53 7.53 7.53 7.53 7.53 7.53 7.53 7.53 7.53 7.53 Total Reserves 25.89 22.10 16.86 12.73 10.73 9.52 8.69 6.88 5.53 1.98 Non-Current Liabilities 14.31 14.02 16.24 12.41 9.26 8.57 5.98 5.06 4.57 2.24 Secured Loans 4.93 4.51 7.23 4.66 3.68 2.02 0.09 0.13 0.00 0.00 Unsecured Loans 7.02 7.27 7.26 6.50 4.33 4.58 4.30 3.79 3.64 2.42 Long Term Provisions 0.71 0.72 0.79 0.67 0.57 0.55 0.39 0.33 0.31 0.21 Current Liabilities 73.71 57.76 50.51 51.25 46.22 37.41 33.50 31.07 17.11 3.11 Trade Payables 46.15 43.32 29.50 30.27 30.36 23.02 20.06 17.36 8.78 0.56 Other Current Liabilities 4.99 4.66 6.23 5.67 2.49 2.58 2.02 2.13 3.18 2.52 Short Term Borrowings 21.55 8.56 13.59 14.91 13.00 11.54 11.33 11.56 4.84 0.00 Short Term Provisions 1.02 1.23 1.19 0.39 0.36 0.27 0.09 0.02 0.31 0.03 Total Liabilities 121.44 101.41 91.14 83.92 73.74 63.03 55.70 50.54 34.74 14.86 Net Block 24.91 26.25 22.43 13.81 14.97 14.56 12.77 8.73 7.28 8.21 Gross Block 46.28 49.57 44.05 34.21 34.20 32.70 29.93 25.08 23.11 24.88 Accumulated Depreciation 21.37 23.32 21.62 20.40 19.23 18.15 17.16 16.35 15.83 16.67 Non Current Assets 34.43 27.08 23.53 23.09 17.24 15.73 13.07 10.15 7.88 8.39 Capital Work in Progress 9.08 0.49 0.76 8.93 2.05 0.97 0.12 1.20 0.42 0.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 0.34 0.23 0.33 0.35 0.23 0.21 0.19 0.22 0.19 0.19 Other Non Current Assets 0.10 0.10 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 87.01 74.33 67.61 60.83 56.49 47.29 42.63 40.40 26.86 6.47 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 19.86 10.03 14.65 17.75 16.47 13.47 11.32 10.74 9.28 3.04 Sundry Debtors 57.94 55.58 45.12 36.02 33.96 26.78 24.17 24.55 13.13 0.51 Cash & Bank 3.08 2.28 1.64 1.43 1.53 1.62 0.88 0.65 0.26 0.25 Other Current Assets 6.13 0.24 0.31 0.43 4.55 5.42 6.25 4.45 4.18 2.67 Short Term Loans & Adv. 5.84 6.20 5.90 5.20 4.28 5.25 2.08 1.52 1.96 1.14 Net Current Assets 13.30 16.57 17.10 9.58 10.28 9.88 9.13 9.32 9.75 3.36 Total Assets 121.44 101.41 91.14 83.92 73.73 63.02 55.70 50.55 34.74 14.86

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 13.22 11.23 1.33 6.24 3.71 3.82 5.15 -4.53 -5.85 2.24 PBT 4.93 7.02 5.69 6.36 5.72 4.72 2.71 1.35 3.65 1.55 Adjustment 5.22 4.27 4.13 -0.33 -0.24 -0.68 2.51 0.56 2.42 0.66 Changes in Working Capital 4.22 1.72 -6.92 0.60 -1.49 0.35 0.43 -5.66 -11.50 -0.21 Cash after chg. in Working capital 14.37 13.01 2.91 6.63 3.99 4.39 5.65 -3.75 -5.43 2.01 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -1.15 -1.78 -1.58 -0.39 -0.28 -0.57 -0.50 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.78 -0.42 0.23 Cash From Investing Activity -8.64 -4.97 -1.25 -6.68 -2.34 -2.95 -2.97 -2.08 -0.20 -2.29 Net Fixed Assets -5.30 -5.25 -1.67 -6.89 -2.58 -3.62 -3.77 -2.75 1.35 -2.06 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -3.34 0.28 0.42 0.21 0.24 0.67 0.80 0.67 -1.55 -0.23 Cash from Financing Activity -3.77 -5.62 0.13 0.34 -1.46 -0.14 -1.95 6.99 6.07 0.02 Net Cash Inflow / Outflow 0.81 0.64 0.21 -0.10 -0.09 0.73 0.23 0.39 0.01 -0.02 Opening Cash & Equivalents 2.28 1.64 1.43 1.53 1.62 0.88 0.65 0.26 0.25 0.27 Closing Cash & Equivalent 3.08 2.28 1.64 1.43 1.53 1.62 0.88 0.65 0.26 0.25

Financial Ratios

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 44.38 39.35 32.38 26.90 24.24 22.64 21.54 19.14 17.34 12.63 ROA 3.40% 5.45% 4.72% 2.54% 1.77% 1.40% 3.41% 3.17% 14.70% 10.41% ROE 12.01% 19.42% 18.49% 10.39% 6.85% 4.99% 11.81% 9.84% 32.32% 17.77% ROCE 14.53% 18.35% 17.58% 11.80% 12.14% 11.01% 16.89% 15.77% 32.30% 8.18% Fixed Asset Turnover 3.33 3.44 3.13 2.80 2.50 2.06 3.01 3.29 2.56 0.40 Receivable days 129.78 114.07 120.71 133.44 132.67 144.27 107.28 86.78 40.47 22.83 Inventory Days 34.17 27.96 48.21 65.26 65.40 70.21 48.60 46.13 36.54 119.31 Payable days 127.50 101.87 112.95 144.33 126.35 136.13 96.09 74.44 33.66 32.99 Cash Conversion Cycle 36.45 40.16 55.97 54.37 71.71 78.35 59.79 58.47 43.35 109.14 Total Debt/Equity 1.07 0.78 1.25 1.36 1.21 1.12 0.97 1.08 0.65 0.25 Interest Cover 2.26 3.46 2.72 1.79 1.60 1.54 2.08 2.16 8.05 4.37

Top Investors:

highcrestt global company ltd

gautam chand jain

umesh kumar gupta

swet realtors pvt. ltd.

gopalakrishnan. v.

Annual Reports:

News Update:

Godavari Drugs - Quarterly Results
13th Feb 2024, 17:52 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback